不同亚型膀胱癌的最佳围手术期治疗是什么？

IF 5.6 2区医学 Q1 UROLOGY & NEPHROLOGY

European urology focus Pub Date : 2025-07-23 DOI:10.1016/j.euf.2025.07.003

Scott M Gilbert

{"title":"不同亚型膀胱癌的最佳围手术期治疗是什么？","authors":"Scott M Gilbert","doi":"10.1016/j.euf.2025.07.003","DOIUrl":null,"url":null,"abstract":"Urothelial carcinoma subtypes are classified according to the 2022 World Health Organization scheme and are generally high-risk cancers that require multidisciplinary evaluation and management whenever possible. Perioperative systemic therapies (neoadjuvant and adjuvant) should be considered for subtypes that are responsive, but some very rare subtypes do not respond well to systemic therapy. Concerted efforts are needed to identify better therapies for these tumors.","PeriodicalId":12160,"journal":{"name":"European urology focus","volume":" ","pages":""},"PeriodicalIF":5.6000,"publicationDate":"2025-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"What Is the Optimal Perioperative Treatment for Variant Subtypes of Bladder Cancer?\",\"authors\":\"Scott M Gilbert\",\"doi\":\"10.1016/j.euf.2025.07.003\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Urothelial carcinoma subtypes are classified according to the 2022 World Health Organization scheme and are generally high-risk cancers that require multidisciplinary evaluation and management whenever possible. Perioperative systemic therapies (neoadjuvant and adjuvant) should be considered for subtypes that are responsive, but some very rare subtypes do not respond well to systemic therapy. Concerted efforts are needed to identify better therapies for these tumors.\",\"PeriodicalId\":12160,\"journal\":{\"name\":\"European urology focus\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":5.6000,\"publicationDate\":\"2025-07-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European urology focus\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.euf.2025.07.003\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European urology focus","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.euf.2025.07.003","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}

引用次数: 0

摘要

尿路上皮癌亚型根据2022年世界卫生组织方案进行分类，通常是高风险癌症，需要尽可能进行多学科评估和管理。对于反应良好的亚型，应考虑围手术期全身治疗（新辅助和辅助），但一些非常罕见的亚型对全身治疗反应不佳。需要共同努力来确定更好的治疗这些肿瘤的方法。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

What Is the Optimal Perioperative Treatment for Variant Subtypes of Bladder Cancer?

Urothelial carcinoma subtypes are classified according to the 2022 World Health Organization scheme and are generally high-risk cancers that require multidisciplinary evaluation and management whenever possible. Perioperative systemic therapies (neoadjuvant and adjuvant) should be considered for subtypes that are responsive, but some very rare subtypes do not respond well to systemic therapy. Concerted efforts are needed to identify better therapies for these tumors.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

European urology focus Medicine-Urology

CiteScore

10.40

自引率

3.70%

发文量

274

审稿时长

23 days

期刊介绍： European Urology Focus is a new sister journal to European Urology and an official publication of the European Association of Urology (EAU). EU Focus will publish original articles, opinion piece editorials and topical reviews on a wide range of urological issues such as oncology, functional urology, reconstructive urology, laparoscopy, robotic surgery, endourology, female urology, andrology, paediatric urology and sexual medicine. The editorial team welcome basic and translational research articles in the field of urological diseases. Authors may be solicited by the Editor directly. All submitted manuscripts will be peer-reviewed by a panel of experts before being considered for publication.